Zevra Therapeutics, Inc. (ZVRA)

Zevra Therapeutics Statistics

Total Valuation

ZVRA has a market cap or net worth of $423.77 million. The enterprise value is $414.57 million.

Market Cap	423.77M
Enterprise Value	414.57M

Important Dates

The next confirmed earnings date is Tuesday, May 13, 2025, after market close.

Earnings Date	May 13, 2025
Ex-Dividend Date	n/a

Share Statistics

ZVRA has 54.68 million shares outstanding. The number of shares has increased by 30.46% in one year.

Current Share Class	54.68M
Shares Outstanding	54.68M
Shares Change (YoY)	+30.46%
Shares Change (QoQ)	+11.85%
Owned by Insiders (%)	6.54%
Owned by Institutions (%)	49.10%
Float	43.29M

Valuation Ratios

PE Ratio	n/a
Forward PE	92.54
PS Ratio	15.18
Forward PS	4.56
PB Ratio	10.49
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	17.56
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.53, with a Debt / Equity ratio of 1.52.

Current Ratio	2.53
Quick Ratio	2.35
Debt / Equity	1.52
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-11.84

Financial Efficiency

Return on equity (ROE) is -207.84% and return on invested capital (ROIC) is -52.90%.

Return on Equity (ROE)	-207.84%
Return on Assets (ROA)	-31.03%
Return on Invested Capital (ROIC)	-52.90%
Return on Capital Employed (ROCE)	-60.39%
Revenue Per Employee	$400,203
Profits Per Employee	-$1.79M
Employee Count	59
Asset Turnover	0.13
Inventory Turnover	n/a

Taxes

In the past 12 months, ZVRA has paid $15.37 million in taxes.

Income Tax	15.37M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +60.79% in the last 52 weeks. The beta is 1.87, so ZVRA's price volatility has been higher than the market average.

Beta (5Y)	1.87
52-Week Price Change	+60.79%
50-Day Moving Average	7.56
200-Day Moving Average	7.86
Relative Strength Index (RSI)	55.38
Average Volume (20 Days)	443,265

Short Selling Information

The latest short interest is 5.60 million, so 10.24% of the outstanding shares have been sold short.

Short Interest	5.60M
Short Previous Month	5.92M
Short % of Shares Out	10.24%
Short % of Float	12.94%
Short Ratio (days to cover)	11.31

Income Statement

In the last 12 months, ZVRA had revenue of $23.61 million and -$105.51 million in losses. Loss per share was -$2.28.

Revenue	23.61M
Gross Profit	16.20M
Operating Income	-87.00M
Pretax Income	-50.87M
Net Income	-105.51M
EBITDA	-80.61M
EBIT	-87.00M
Loss Per Share	-$2.28

Balance Sheet

The company has $69.50 million in cash and $60.30 million in debt, giving a net cash position of $9.20 million or $0.17 per share.

Cash & Cash Equivalents	69.50M
Total Debt	60.30M
Net Cash	9.20M
Net Cash Per Share	$0.17
Equity (Book Value)	39.67M
Book Value Per Share	0.74
Working Capital	51.96M

Cash Flow

Operating Cash Flow	-69.67M
Capital Expenditures	n/a
Free Cash Flow	-69.67M
FCF Per Share	-$1.27

Margins

Gross Margin	68.59%
Operating Margin	-368.47%
Pretax Margin	-381.76%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ZVRA does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-30.46%
Shareholder Yield	-30.46%
Earnings Yield	-24.90%
FCF Yield	-16.44%

Analyst Forecast

The average price target for ZVRA is $22.29, which is 187.61% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$22.29
Price Target Difference	187.61%
Analyst Consensus	Strong Buy
Analyst Count	8
Revenue Growth Forecast (5Y)	75.49%
EPS Growth Forecast (5Y)	n/a

Stock Splits

The last stock split was on December 28, 2020. It was a reverse split with a ratio of 0.0625:1.

Last Split Date	Dec 28, 2020
Split Type	Reverse
Split Ratio	0.0625:1

Scores

ZVRA has an Altman Z-Score of -3.76 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-3.76
Piotroski F-Score	2